| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.3M | +36.7% |
| Cost of Revenue | $11.8M | -8.2% |
| Gross Profit | $31.4M | +67.5% |
| R&D Expense | $67.9M | +19.2% |
| SG&A Expense | $26.9M | +2.5% |
| Operating Income | -$63.3M | +1.7% |
| Pre-tax Income | -$44.5M | +16.5% |
| Income Tax | $845K | -11.6% |
| Net Income | -$45.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $121.3M | +76.4% |
| Short-term Investments | $26.0M | — |
| Accounts Receivable | $972K | +235.2% |
| Current Assets | $187.4M | +81.6% |
| Total Assets | $202.6M | +69.6% |
| Current Liabilities | $16.8M | -24.7% |
| Total Liabilities | $68.6M | -29.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.6M | -36.8% |
| Capital Expenditures | $211K | +276.8% |
| Investing Cash Flow | -$22.0M | -213.8% |
| Financing Cash Flow | $142.1M | +344.9% |
| Free Cash Flow | -$67.9M | -37.0% |
| +16.4% |
| EPS (Basic) | -$0.33 | +32.7% |
| EPS (Diluted) | -$0.33 | +32.7% |
| Stockholders' Equity |
| $134.0M |
| +509.4% |